The prospective French participitation to IDEA (International Duration Evaluation of Adjuvant Chemotherapy) study in stage III colon cancer: Patients’ characteristics and safety analysis of 3 versus 6 months of adjuvant chemotherapy.

Authors

Thierry Andre

Thierry Andre

Hôpital Saint-Antoine, Paris, France

Thierry Andre , Aimery De Gramont , Laurent Mineur , Jérôme Desramé , Roger Faroux , Jaafar Bennouna , Jérôme Dauba , Christophe Louvet , Simon Pernot , Olivier Jean Marie Dupuis , Yves Becouarn , May Mabro , Joëlle Egreteau , Olivier Bouche Sr., Franck Bonnetain , Marine Hug de Larauze , Karine Le Malicot , Julien Taieb

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

2009-010384-16

Citation

J Clin Oncol 34, 2016 (suppl 4S; abstr 633)

DOI

10.1200/jco.2016.34.4_suppl.633

Abstract #

633

Poster Bd #

G16

Abstract Disclosures